Mergers & Acquisitions
Feb. 14, 2014
Dealmakers
A roundup of recent merger and acquisition and financing activity and the lawyers involved.
Latham advises on $1.3B billion cross-border pharma deal
Latham & Watkins LLP advised San Diego-based drugmaker Cadence Pharmaceuticals Inc. in its $1.3 billion sale to Mallinckrodt PLC, a deal announced Tuesday.
Mallinckrodt, a pharmaceutical company headquartered in Dublin, Ireland, received counsel from Wachtell, Lipton, Rosen & Katz. New York partners Adam O. Emmerich and Benjamin M. Roth...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In